BioDot Ltd. has Relocated to New Premises
News Oct 07, 2005
BioDot Ltd has announced that it has relocated its European headquarters. The relocation expands BioDot’s sales and support capabilities in Europe.
Andrew Sweet, BioDot Ltd's Managing Director, comments, "The investment BioDot has put into the facility will enable it to meets its expansion objectives over the next 5 years, both in terms of physical size, and for the improvement in applications, service and sales support."
John Witton, BioDot Ltd's Sales Director adds, "In line with our commitment to enable, inspire and educate scientists to commercialise their diagnostic tests, we can now provide the facilities that link R&D with manufacturing."
"Our laboratories are being constructed for lateral flow, immunoblot, biosensor and biochip applications work, as well as providing the environment for One Step One Solution education and technology transfer programmes".
Andy Walker, BioDot Ltd's Technical Sales Manager, comments, "the facility provides more space for demonstrating our equipment range, and for our expanding Support Centre."
"The size allows us to demonstrate our in-line manufacturing lines, particularly for lateral flow, biosensor and dry chemistry applications. We are seeing increased demand for our dispensing technologies for molecular diagnostic applications, and the OSOS programmes, coupled with the laboratory facility, will allow us to locally support our European customers."
Immediate contact details are:
Downs Road, West Stoke,
Chichester, West Sussex PO18 9HJ
3D Printer Developed That Can Create Complex Biological TissuesNews
A UCLA bioengineer has developed a technique that uses a specially adapted 3D printer to build therapeutic biomaterials from multiple materials. The advance could be a step toward on-demand printing of complex artificial tissues for use in transplants and other surgeries.READ MORE
Microfluidic Device Captures Extracellular Vesicles Shed by Brain TumorsNews
Because needle biopsies of brain tumors are invasive and difficult, bioengineers supported by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) have developed micro-technologies that capture extracellular vesicles (EVs) released by the tumor.READ MORE
Making Drug Microparticles a Thousand Times FasterNews
Pharmaceuticals owe their effects mostly to their chemical composition, but the packaging of these drugs into specific physical formulations also need to be done to exact specifications. Engineers have now developed a microfluidic system where more than ten thousand devices run in parallel, all on a silicon-and-glass chip that can fit into a shirt pocket.READ MORE